Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate. Interactions with frequently occurring glutamic acid residue at P2' position of substrates

European Journal of Biochemistry

Volumn 249, Issue 2, 1997, Pages 523-530

  Weber, Irene T ^a   Wu, Jin ^a   Adomat, Jill ^a   Harrison, Robert W ^a   Kimmel, Alan R ^b   Wondrak, Ewald M ^b   Louis, John M ^b,c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Crystal structure; Human immunodeficiency virus protease; Proton mediated interaction; Viral maturation

Indexed keywords

GLUTAMIC ACID; PROTEASOME; PROTEINASE;

ARTICLE; CRYSTAL STRUCTURE; ENZYME BINDING; ENZYME STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030669385     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1997.00523.x     Document Type: Article

References (30)

1. Barrie, K. A., Perez, E. E., Lumers, S. L., Farmeric, W. G., Dunn, B. M., Sleasman, J. W. & Goodenow, M. M. (1996) Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1, Virology 219, 407-416.
2. Bhat, T. N., Baldwin, E. T., Liu, B., Cheng, Y.-S. & Erickson, J. W. (1994) Crystal structure of a tethered dimer of HIV-1 proteinase complexed with an inhibitor, Nature Struct. Biol. 1, 552-556.
3. Brunger, A. T. (1992) XPLOR version 3.0 manual, Yale University.
4. Cameron, C. E., Grinde, B., Jacques, P., Jentoft, J., Leis, J., Wlodawer, A. & Weber, I. T. (1993) Comparison of the substrate binding pockets of the rous sarcoma virus and human immunodeficiency virus type 1 proteases, J. Biol. Chem. 268, 11 711-11 720.
5. Darke, P. L., Nutt, R. F., Brady, S. F., Garsky, V. M., Ciccarone, T. M., Leu, C. T., Lumma, P. K., Freidinger, R. M., Vebal, D. F. & Sigal, I. S. (1988) HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins, Biochem. Biophys. Res. Commun. 156, 297-303.
6. Griffith, J. T., Phylip, L. H., Konvalinka, J., Strop, P., Gustchina, A., Wlodawer, A., Davenport, R. J., Briggs, R., Dunn, B. M. & Kay, J. (1992) Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*Pro-cleavage sites, Biochemistry 31, 5193-5200.
7. Gustchina, A., Sansom, C., Prevost, M., Richelle, J., Wodak, S. Y., Wlodawer, A. & Weber, I. T. (1994) Energy calculations and analysis of HIV-1 protease-inhibitor crystal structures, Protein Eng. 7, 309-317.
8. Jones, T. A. (1985) Diffraction methods for biological macromolecules. Interactive computer graphics: FRODO, Methods Enzymol. 115, 157-171.
9. Kohl, N. E., Emini, E. A., Schleif, W. A., Davis, L. J., Heimbach, J. C., Dixon, R. A. F., Scolnick, E. M. & Sigal, I. S. (1988) Active human immunodeficiency virus protease is required for viral infectivity, Proc. Natl Acad. Sci. USA 85, 4686-4690.
10. Kozal, M. J., Shah, N., Shen, N., Yang, R., Fucini, R., Merigan, T. C., Richman, D. D., Morris, D., Hubbell, E., Chee, M. & Gingeras, T. R. (1996) Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays, Nature Med. 2, 753-759.
11. Mildner, A. M., Rothrock, D. J., Leone, J. W., Bannow, C. A., Lull, J. M., Reardon, I. M., Sarcich, J. L., Howe, W. J., Tomich, C.-S. C., Smith, C. W., Heinrickson, R. L. & Tomasselli, A. G. (1994) The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties, Biochemistry 33, 9405-9413.
12. Miller, M., Schneider, J., Sathyanarayana, B. K., Toth, M. V., Marshall, G. R., Clawson, L., Selk, L., Kent, S. & Wlodawer, A. (1989) Structure of a complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 Å resolution, Science 246, 1149-1152.
13. Oroszlan, S. & Luftig, R. B. (1990) Retroviral proteinases, Curr. Top. Microbiol. Immunol. 157, 153-185.
14. Pettit, S. C., Moody, M. D., Wehbie, R. S., Kaplan, A. H., Nantermet, P. V. Klein, C. A. & Swanstrom, R. (1994) The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions, J. Virol. 68, 8017-8027.
15. Polgar, L., Szeltner, Z. & Boros, I. (1994) Substrate-dependent mechanisms in the catalysis of human immunodeficiency virus protease, Biochemistry 33, 9351-9357.
16. Poorman, R. A., Tomasselli, A. G., Heinrikson, R. L. & Kezdy, F. J. (1991) A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base, J. Biol. Chem. 266, 14 554-14 561.
17. Rose, R. B., Craik, C. S., Douglas, N. L. & Stroud, R. M. (1996) Three-dimensional structures of HIV-1 and SIV protease product complexes, Biochemistry 35, 12 933-12 944.
18. Schinazi, R. F., Larder, B. A. & Mellors, J. W. (1996) Mutations in retroviral genes associated with drug resistance, Int. Antiviral News 4, 95-107.
19. Serio, D., Rizvi, T. A., Cartas, M., Kalyanaraman, V. S., Weber, I. T., Koprowski, H. & Srinivasan, A. (1997) Development of a novel anti-HIV-1 agent from within: effect of chimeric Vpr containing protease cleavage site residues on virus replication, Proc. Natl Acad. Sci. USA 94, 3346-3351.
20. Swain, A. L., Miller, M., Green, J., Rich, D. H., Schneider, J., Kent, S. B. H. & Wlodawer, A. (1990) X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor, Proc. Natl Acad. Sci. USA 87, 8805-8809.
21. Swanstrom, R., Kaplan, A. H. & Manchester, M. (1990) The aspartic proteinase of HIV-1, Virology 1, 175.
22. Tong, L., Pav, S., Pargellis, C., Do, F., Lamerre, D. & Anderson, P. C. (1993) Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures, Proc. Natl Acad. Sci. USA 90, 8387-8391.
23. Tozser, J., Gustchina, A., Weber, I. T., Blaha, I., Wondrak, E. M. & Oroszlan, S. (1991) Studies on the role of the S4 substrate binding site of HIV proteinases, FEBS Lett. 279, 356-360.
24. Tozser, J., Weber, I. T., Gustchina, A., Blaha, I., Copeland, T. D., Louis, J. M. & Oroszlan, S. (1992) Kinetic and modeling studies of S3-S3′ subsites of HIV proteinases, Biochemistry 31, 4793-4800.
25. Weber, I. T. & Harrison, R. W. (1996) Molecular mechanics calculations on HIV-1 protease with peptide substrates correlate with experimental data, Protein Eng. 9, 679-690.
26. Wlodawer, A., Nachman, J., Gilliland, G. L., Gallagher, W. & Woodward, C. (1987) Structure of form III crystals of bovine pancreatic trypsin inhibitor, J. Mol. Biol. 198, 469-480.
27. Wlodawer, A. & Erickson, J. W. (1993) Structure-based inhibitors of HIV-1 protease, Annu. Rev. Biochem. 62, 543-585.
28. Wondrak, E. M., Nashed, N. T., Haber, M. T., Jerina, D. M. & Louis, J. M. (1996) A transient precursor of the HIV-1 protease: isolation, characterization and kinetics of maturation, J. Biol. Chem. 271, 4477-4481.
29. Yamazaki, T., Nicholson, L. K., Torchia, D. A., Wingfield, P., Stahl, S. J., Kaufman, J. D., Eyermann, C. J., Hodge, C. N., Lam, P. Y. S., Ru, Y., Jadhav, P. K., Chang, C.-H. & Weber, P. C. (1994) NMR and X-ray evidence that the HIV protease catalytic aspartyl groups are protonated in the complex formed formed by the protease and a non-peptide cyclic urea-based inhibitor. J. Am. Chem. Soc. 116, 10 791-10 792.
30. Zegers, I., Maes, D., Dao-Thi, M.-H., Poortmans, F., Palmer, R. & Wyns, L. (1994) The structures of RNase A complexed with 3′CMP and d(CpA): active site conformation and conserved water molecules, Protein Sci. 3, 2322-2339.